Prior research has found that adults with T1D and obesity who participated in a BLI for adults with diabetes demonstrated significantly reduced body weight, HbA1C, and total insulin doses prescribed compared to a matched usual care control group [37]. The gene discussed is INS; the disease is obesity disorder.